Klaria Pharma (Sweden) Today
| KLAR Stock | SEK 0.45 0.03 6.25% |
Performance3 of 100
| Odds Of DistressLess than 10
|
Klaria Pharma is selling for under 0.45 as of the 1st of December 2024; that is 6.25 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 0.4. Klaria Pharma has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. Equity ratings for Klaria Pharma Holding are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 2nd of September 2024 and ending today, the 1st of December 2024. Click here to learn more.
Klaria Pharma Holding AB develops treatment methods in the therapeutic fields of migraine and pain related to cancer worldwide. Klaria Pharma Holding AB was founded in 2014 and is based in Uppsala, Sweden. Klaria Pharma is traded on Stockholm Stock Exchange in Sweden. The company has 63.1 M outstanding shares. More on Klaria Pharma Holding
Moving against Klaria Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Klaria Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Klaria Pharma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Klaria Pharma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Drug Manufacturers - Specialty & Generic, Healthcare (View all Sectors) |
Klaria Pharma Holding (KLAR) is traded on Stockholm Exchange in Sweden and employs 6 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 39.49 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Klaria Pharma's market, we take the total number of its shares issued and multiply it by Klaria Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Klaria Pharma Holding operates under Healthcare sector and is part of Drug Manufacturers - Specialty & Generic industry. The entity has 63.1 M outstanding shares.
Klaria Pharma Holding has accumulated about 25.49 M in cash with (24.8 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.47, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Klaria Pharma Probability Of Bankruptcy
Ownership AllocationKlaria Pharma Holding maintains a total of 63.1 Million outstanding shares. Klaria Pharma Holding secures 10.73 % of its outstanding shares held by insiders and 9.75 % owned by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Klaria Ownership Details
Klaria Pharma Holding Risk Profiles
Although Klaria Pharma's alpha and beta are two of the key measurements used to evaluate Klaria Pharma's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 5.8 | |||
| Semi Deviation | 7.5 | |||
| Standard Deviation | 8.77 | |||
| Variance | 76.95 |
Klaria Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Klaria Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Volatility Now
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk |
| All Next | Launch Module |
Klaria Pharma Corporate Management
Elected by the shareholders, the Klaria Pharma's board of directors comprises two types of representatives: Klaria Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Klaria. The board's role is to monitor Klaria Pharma's management team and ensure that shareholders' interests are well served. Klaria Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Klaria Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Hans MD | Chief Officer | Profile | |
| Hans Richter | Chief Consultative | Profile | |
| Susan Suchdev | Chief Officer | Profile | |
| Fredrik Hubinette | Chairman CTO | Profile | |
| Marc Willuhn | Manufacturing Chemistry | Profile | |
| Jesper Wiklund | Chief Officer | Profile |
Additional Tools for Klaria Stock Analysis
When running Klaria Pharma's price analysis, check to measure Klaria Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Klaria Pharma is operating at the current time. Most of Klaria Pharma's value examination focuses on studying past and present price action to predict the probability of Klaria Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Klaria Pharma's price. Additionally, you may evaluate how the addition of Klaria Pharma to your portfolios can decrease your overall portfolio volatility.